Turanabol Tablets
Overview
Turanabol Tablets British Dragon delivers oral turinabol (4-chlorodehydromethyltestosterone) at 10 mg per tablet in a 100-tablet pack — 1,000 mg total. Structurally, oral turinabol is a modified testosterone molecule with a 4-chloro substituent added at the C4 position and a double bond between C1 and C2 — features that collectively eliminate aromatization, block 5-alpha reductase conversion to a more androgenic metabolite, and reduce overall androgenic activity relative to testosterone. The result is a 17-alpha-alkylated oral anabolic with a moderate anabolic profile, low androgenic liability, and no estrogen-driven side effects: no water retention, no gynecomastia risk from the compound itself, and no AI requirement from Turinabol. What it does produce is lean, dry, gradually-accrued mass and strength gains suitable for cutting phases, pre-contest preparation, or as a cycle kickstart while long-ester injectables build to steady state. Steroid Warehouse carries Turanabol BD alongside the full British Dragon oral range for athletes selecting compound format based on their cycle context.
About the Compound
Oral turinabol was developed by Jenapharm in the German Democratic Republic in 1965 and became the cornerstone of State Plan 14.25 — the systematic East German doping program that administered Tbol to Olympic athletes across multiple disciplines from the 1970s through to 1989. The compound was selected precisely for the characteristics that make it useful today: detectable anabolic effect without the water weight and estrogenic side effects of testosterone or Dianabol, a manageable androgenic profile, and (at the time) the absence of established detection methods. Its long detection window for metabolites in modern testing — up to 12 months for the 4-chloro-CDHMT glucuronide metabolite in urine — is now well-documented and means Turanabol is not appropriate for competition-tested athletes.
Chemically, Turanabol combines the structural modifications of Dianabol (a 17-alpha-methyl group enabling oral bioavailability, and a C1-C2 double bond) with a 4-chloro substituent at the C4 position. The 4-chloro group is responsible for two distinct outcomes: it renders the molecule resistant to aromatization (aromatase cannot bind the 4-chloro-bearing substrate), and it blocks 5-alpha reductase conversion — meaning turinabol does not convert to a more androgenic DHT-analog in peripheral tissues. Both outcomes reduce androgenic side-effect liability relative to Dianabol while preserving anabolic receptor activity. The tradeoff is a slower, more modest rate of lean mass accrual compared to wetter aromatizing compounds, which is precisely the desired characteristic for athletes who prioritise quality over scale weight.
What It Does
- Lean mass accrual without water retention: turinabol's non-aromatizing profile means all mass gained on a Tbol cycle is lean muscle tissue; no glycogen-driven intracellular water accompanies gains; the scale weight increase during a Turanabol cycle is a reliable proxy for actual lean tissue gained — a practical advantage for athletes monitoring body composition who do not want to parse water gains from muscle gains at the end of a cycle.
- Strength increase proportional to lean mass gained: unlike Dianabol, where a significant portion of early strength gain is attributable to neuromuscular water loading and glycogen expansion, Tbol-driven strength increases are primarily myofibrillar; gains come more slowly than on Dianabol but are retained at a higher proportion after the cycle ends because they are not water-dependent.
- SHBG binding — partial testosterone liberation when stacked: turinabol has measurable affinity for sex hormone binding globulin (SHBG); at doses of 40–60 mg/day, Tbol competes with endogenous and exogenous testosterone for SHBG binding sites, freeing a modest additional fraction of active free testosterone; this synergistic effect makes Tbol a practical stacking compound alongside a testosterone base rather than a standalone high-dose oral.
- Cycle kickstart while injectables build: long-ester injectable testosterone (enanthate, cypionate) requires 3–4 weeks to reach stable blood levels; running Turanabol BD at 40–50 mg/day for the first 4–6 weeks bridges this onset gap, providing anabolic activity from week 1 while the injectable reaches plateau; unlike a Dianabol kickstart, the Tbol kickstart does not require AI management or produce the estrogenic bloat that distorts early body composition assessment.
- Hepatotoxicity via 17α-alkylation — limits cycle duration: like all orally bioavailable 17-AA compounds, Turanabol passes through the liver unchanged on first pass; this produces dose-dependent ALT and AST elevation; the hepatotoxic burden of Tbol is considered lower than Dianabol or stanozolol at equivalent doses, but it is real and measurable; liver enzymes should be monitored and oral use should not exceed 8 weeks.
Who It's For
Turanabol BD is for intermediate AAS users who have completed at least one testosterone-only cycle, understand their individual response to oral steroids, and are selecting an oral compound specifically for its non-aromatizing, dry-gains profile. Its primary use case is either as a cycle kickstart alongside a long-ester testosterone base, or as the oral component of a cutting/recomposition cycle where estrogen-driven water weight is undesirable.
The core differentiator of Turanabol from other BD oral options is the combination of anabolic activity, zero aromatization, and low androgenic liability in a single compound. Users who want fast, large-scale mass gains with maximum anabolic output are better served by Dianabol 20 Dragon Pharma — which produces significantly more scale weight and strength accrual at the cost of E2 management and water retention. Users who want the mildest possible oral with the lowest androgenic and hepatic burden and are willing to pay a premium for it may prefer Anavar. Turanabol occupies the middle ground: more anabolic potency than Anavar at a lower cost per mg, cleaner than Dianabol with no water, and better-tolerated for longer runs than stanozolol.
Users who should not choose Turanabol BD as their first oral: beginners should establish their response to testosterone alone before adding oral compounds; Tbol suppresses LH/FSH and requires a testosterone base on all cycles. Athletes subject to competition drug testing should not use oral turinabol — the detection window for metabolites in urine testing extends up to 12 months with current analytical methods, making it one of the least appropriate compounds for tested sport regardless of perceived half-life.
Turanabol vs Alternatives
| Compound | Key Differences | Choose Turanabol BD When | Choose Alternative When |
|---|---|---|---|
| Dianabol 20 Dragon Pharma (methandrostenolone 20 mg/tab) | Both are 17-AA oral testosterone derivatives with a C1–C2 double bond; Dianabol lacks the 4-chloro substituent — it aromatizes significantly and requires AI management; Dianabol produces faster and larger mass and strength gains driven partly by E2 elevation and water retention; Turanabol produces slower, drier, leaner gains with no estrogen-related side effects; Dianabol has higher androgenic activity and more hepatotoxic stress per mg; Turanabol gains are retained at a higher proportion post-cycle; Dianabol is typically run at 30–50 mg/day vs Turanabol 40–60 mg/day for comparable anabolic output | Goal is dry lean mass with no E2 management overhead; kickstart without estrogenic bloat; cutting or recomposition phase; user is estrogen-sensitive or avoids AI compounds | Maximum mass and strength gain in minimum time; bulking cycle at caloric surplus; estrogenic side effects are acceptable and AI management is in place; scale weight increase is the primary metric; Dianabol's faster onset is needed for a very short kickstart window |
| Anavar 10 Dragon Pharma (oxandrolone 10 mg/tab) | Both are non-aromatizing orals with dry lean mass profiles; oxandrolone is a DHT derivative vs Tbol's testosterone-derived structure; oxandrolone does not suppress LH/FSH as completely as Tbol at equivalent doses, making it a better standalone option; oxandrolone is considered less hepatotoxic than Tbol; oxandrolone produces more pronounced strength-to-weight gains favoured in powerlifting and weight-class sports; Turanabol produces more overall lean mass accrual at comparable doses; Anavar is significantly more expensive per mg than Turanabol | Volume of lean mass is the priority over pure strength-to-weight ratio; cost efficiency matters; longer oral cycles (up to 8 weeks) where Tbol's slightly higher anabolic output per mg is leveraged | Strength-to-weight ratio is the primary goal (powerlifting, weight-class sports); lowest possible hepatotoxic burden is required; partial HPG-axis maintenance during the cycle is preferred; budget permits the higher cost per mg of Anavar |
| Winstrol 10 Dragon Pharma (stanozolol 10 mg/tab) | Both are non-aromatizing 17-AA orals with dry, non-water profiles; stanozolol is a DHT derivative with higher androgenic activity than Tbol; stanozolol notoriously suppresses HDL cholesterol more severely than Tbol; stanozolol causes joint dryness and discomfort at higher doses, particularly in cutting phases where body fat and water are already low; Turanabol is better tolerated for 6–8 week runs; stanozolol produces harder, denser cosmetic conditioning preferred in late pre-contest phases; both have similar hepatotoxic profiles at comparable doses | Longer oral phase (6–8 weeks) where joint comfort matters; lean mass accrual rather than pure cosmetic conditioning; lower HDL impact is preferred; androgenic side effects (acne, hairline) are a concern | Maximum cosmetic hardness and vascularity in the final 4–6 weeks pre-contest; joint dryness is not an issue at current body fat levels; higher androgenic output is acceptable; cycle is short (4–6 week finishing phase) |
Combinations
| Goal | Primary | Support Compounds | Notes |
|---|---|---|---|
| Cycle kickstart — bridge while test enanthate builds | Turanabol BD 50 mg/day (wks 1–6) | Testabol Enanthate BD 500 mg/wk 2×/week (wks 1–14) + Anastrozole BD | Turanabol BD provides anabolic activity in weeks 1–6 while Testabol Enanthate BD builds toward steady state (reached at week 3–4); no AI is needed from Turanabol itself — AI is dosed against the testosterone component only; Turanabol BD stopped at week 6; Testabol Enanthate BD continues to week 14; PCT starts 14–21 days after the last testosterone injection; body composition assessment at week 7 (after Tbol clears) reflects clean lean tissue gains without Tbol-driven water |
| Lean mass — shorter cycle with fast-clearing testosterone base | Turanabol BD 50 mg/day (wks 1–8) | Testabol Propionate BD 350 mg/wk EOD (wks 1–10) + Anastrozole BD | Testabol Propionate BD (testosterone propionate, fast-clearing) provides a testosterone base that reaches stable levels in 5–7 days — aligned with Turanabol's own fast onset; both compounds are active from week 1 without a delayed build phase; cycle total length 10 weeks; stop Turanabol BD at week 8, continue Testabol Propionate BD to week 10; PCT starts 3–5 days after the last propionate injection; monitor ALT/AST at week 4 and at Tbol completion |
| Recomposition — lean mass with hardening and low estrogen load | Turanabol BD 40 mg/day (wks 1–6) | Testabol Enanthate BD 300 mg/wk + Mastabol 100 BD (masteron propionate) 300 mg/wk EOD + Anastrozole BD | Three-compound recomposition stack with minimal estrogenic load; Mastabol 100 BD (drostanolone propionate) contributes hardness and anti-estrogenic tissue effect, reducing AI requirement; Turanabol BD's SHBG-binding effect frees additional testosterone fractions alongside Mastabol's own SHBG interaction; keep Testabol Enanthate BD at minimum effective dose (300 mg/wk); Turanabol stopped at week 6 while injectables continue; suitable for athletes below 15% body fat targeting conditioning improvements |
| Quality mass with Primobolan — extended low-androgenic lean cycle | Turanabol BD 50 mg/day (wks 1–6) | Testabol Enanthate BD 400 mg/wk + Primobol Inject BD (methenolone enanthate) 400 mg/wk + Anastrozole BD | A three-compound lean mass cycle combining two non-aromatizing injectables (Primobol Inject BD and Testabol Enanthate BD minimised) with Turanabol as the oral kickstart component; all three compounds have low androgenic profiles; AI requirement is low given the reduced testosterone dose; Turanabol covers weeks 1–6 while Primobol Inject BD and Testabol Enanthate BD run 12–14 weeks; suitable for experienced athletes prioritising lean mass quality over quantity; liver monitoring mandatory given the oral component |
Side Effects & Management
| Side Effect | Frequency | How to Handle It |
|---|---|---|
| Hepatotoxicity — ALT/AST elevation | Consistent; all 17α-alkylated orals elevate liver enzymes; Turanabol's hepatotoxic burden is considered moderate among oral AAS — less than Dianabol or stanozolol at equivalent doses, more than oxandrolone; elevation is dose- and duration-dependent | Mandatory baseline ALT/AST before starting; mid-cycle liver panel at week 4; limit cycle duration to 8 weeks maximum; avoid co-administration with other 17-AA orals or hepatotoxic medications (acetaminophen, statins, alcohol); Liv52 herbal liver support 2 tabs twice daily throughout the oral phase; Mucinac (NAC/acetylcysteine) 600 mg twice daily provides antioxidant hepatic support; if ALT exceeds 3× upper limit of normal, stop the oral and retest in 2–3 weeks |
| HDL suppression — lipid disruption | Common; less severe than stanozolol but measurable; Turanabol reduces HDL to a degree consistent with other 17-AA orals at 40–60 mg/day; compounded when stacked with other lipid-affecting compounds (masteron, trenbolone) | Baseline lipid panel mandatory; omega-3 4 g/day throughout; mid-cycle lipid panel at week 4; Atorvastatin 40 mg DP if LDL exceeds 160 mg/dL; avoid combining with oral stanozolol (Stanabol BD) in the same cycle — both suppress HDL and compound liver load; post-cycle lipid recovery expected within 4–8 weeks |
| HPG axis suppression — testosterone base mandatory | Consistent at 40–60 mg/day; Turanabol suppresses LH and FSH; less complete suppression than testosterone or trenbolone, but sufficient to cause symptomatic low testosterone without a testosterone base; running Tbol without a base produces fatigue, libido suppression, and mood effects within 2–3 weeks | A testosterone base is required on every Turanabol cycle; minimum effective dose of Testabol Enanthate BD or Testabol Propionate BD; do not rely on Turanabol alone for anabolic hormone activity |
| Androgenic effects (acne, hair thinning) | Uncommon to mild; Turanabol's 4-chloro substituent blocks 5AR conversion, preventing amplification of androgenic activity in DHT-sensitive tissues; androgenic side effects are noticeably less frequent than with Dianabol or testosterone at equivalent androgenic output; androgen-sensitive individuals may still experience mild acne at higher doses | Topical skincare for mild acne; dose reduction for persistent androgenic effects; finasteride is not effective for Turanabol-specific androgenicity (no DHT metabolite produced), but does reduce DHT from any testosterone base co-administered; Ecosprin 75 mg/day as cardiovascular support throughout |
| Blood pressure elevation | Mild; Turanabol's non-aromatizing profile reduces the E2-driven BP contribution; BP elevation during Tbol cycles is primarily driven by the testosterone base and any hematocrit rise; less common and less severe than on Dianabol cycles | Weekly BP self-monitoring; target below 130/80 mmHg; manage E2 from the testosterone base with Anastrozole BD; Ecosprin 75 mg/day throughout; Amlip (amlodipine) 5 mg/day if BP persists above target |
Bloodwork Monitoring
| Lab | When to Test | Target & Action Threshold |
|---|---|---|
| ALT & AST (liver enzymes) | Baseline (mandatory before starting); week 4 mid-cycle; 2–3 weeks post-Tbol (after oral phase ends) | Both within reference range at baseline; on-cycle elevation of 1–2× upper limit of normal is typical and acceptable; above 3× upper limit of normal: stop oral immediately and retest in 2–3 weeks; Liv52 and Mucinac throughout the oral phase; post-oral recovery to baseline expected within 4–8 weeks |
| Lipid panel (HDL, LDL, TG) | Baseline; week 4; post-cycle (4–6 weeks after) | HDL above 35 mg/dL on cycle; LDL below 130 mg/dL; Atorvastatin DP if LDL exceeds 160 mg/dL; recovery to baseline within 4–8 weeks post-oral |
| Estradiol (E2) | Baseline; week 3–4 (calibration for testosterone base AI) | Target on cycle: 20–40 pg/mL; Turanabol does not contribute to E2; all AI dosing is calibrated against the testosterone base; if E2 is well-controlled and no estrogenic symptoms are present at week 4, Anastrozole BD dose is confirmed correct |
| Hematocrit & CBC | Baseline; end of cycle | Hematocrit below 52%; Turanabol causes modest erythropoietic stimulation at 40–60 mg/day; Ecosprin 75 mg/day when hematocrit above 48% |
| Blood pressure | Baseline; weekly self-monitoring during cycle | Below 130/80 mmHg; Turanabol contributes less BP elevation than aromatizing orals; monitor for testosterone base-driven E2 and hematocrit contribution |
| LH + FSH | Baseline; post-PCT (4 weeks after completion) | Post-PCT return to pre-cycle baseline; Turanabol clears within 24–48 hours of the last tab (half-life ~16 hours); if paired with long-ester injectable testosterone, PCT timing is governed by the injectable ester, not the oral |
| Total testosterone | Baseline; post-PCT (4 weeks after completion) | Return to pre-cycle baseline; below 300 ng/dL at 6 weeks post-PCT indicates incomplete HPG recovery; document baseline before starting |
PCT
Turanabol has a half-life of approximately 16 hours — it is effectively cleared within 2–3 days of the last tablet. If Turanabol BD is run as a standalone oral (with a short-ester testosterone base such as Testabol Propionate BD), PCT can begin 3–5 days after the last injection of testosterone propionate. If paired with a long-ester injectable (Testabol Enanthate BD), PCT timing is governed by the injectable: 14–21 days after the last enanthate injection, regardless of when the oral phase ended.
Standard 4-week PCT protocol:
- Weeks 1–2: Tamoxifen BD 40 mg/day + Clomiphene BD 50 mg/day
- Weeks 3–4: Tamoxifen BD 20 mg/day + Clomiphene BD 25 mg/day
HCG: For cycles longer than 10 weeks or those using Turanabol BD as a kickstart alongside a long cycle, run HCG 5,000 IU Dragon Pharma at 2,500 IU on two days within the clearance window (beginning 5–7 days post-last-injection, completing at least 5 days before first SERM dose). For short 8–10 week cycles with propionate, HCG is optional but recommended to accelerate Leydig cell recovery. Continue Liv52 and Mucinac through the first 2 weeks of PCT as the liver normalises post-oral phase.
Practical Summary
- Turanabol is a supporting oral, not a standalone anabolic — always pair with a testosterone base: at 40–60 mg/day Tbol suppresses LH and FSH; without a testosterone base, free testosterone falls within 2–3 weeks; the testosterone base provides the androgenic foundation; Turanabol provides the dry, non-estrogenic anabolic layer on top.
- Liver protection from day one — Liv52 twice daily + Mucinac 600 mg twice daily throughout the oral phase: do not add liver support at week 4 when enzyme elevation is detected; start both compounds with the first tablet and run them for the full oral phase plus 2 weeks post-Tbol; avoid all unnecessary hepatotoxic substances (alcohol, acetaminophen at high doses, other 17-AA orals) during the cycle.
- 8 weeks is the hard limit — do not extend Turanabol beyond 8 weeks: 17-AA orals accumulate hepatotoxic stress; the enzyme elevation at week 6–8 is greater than at week 2–4 even at stable doses; plan the cycle end date before starting and commit to it; a second oral compound run at a later date is safer than a single prolonged cycle.
- 50 mg/day × 6 weeks requires approximately 3 packs: 50 mg/day = 5 tabs/day × 42 days = 210 tabs = 2.1 packs; round up to 3 packs to account for the dose range; secure full cycle supply before starting; at 40 mg/day × 6 weeks = 168 tabs = 1.68 packs → 2 packs sufficient.
- No AI needed from Turanabol itself — do not dose AI against the oral: Turanabol does not aromatize; all AI dosing in a Turanabol cycle is calibrated against the testosterone base only; over-suppressing E2 with an AI dosed against phantom Tbol aromatization causes joint pain, low libido, and mood suppression; test E2 at week 3–4 and adjust AI dose based on the reading.
- PCT timing is set by the injectable, not the oral: Turanabol clears within 2–3 days of the last tab; if paired with Testabol Enanthate BD, the 14–21 day clearance window for the injectable governs PCT start; do not begin SERM therapy at day 3 post-last-tab if the injectable is still active.
Turanabol BD from steroidwarehouse.com represents one of the original purpose-built performance orals — a compound with over six decades of documented use in athletic contexts. Its dry, non-aromatizing profile makes it a practical choice for athletes who need an oral anabolic during cutting or kickstart phases without the water retention and estrogen management overhead of Dianabol. Used within the 8-week duration limit with active liver monitoring, a testosterone base, and Liv52 plus NAC hepatic support, Turanabol BD delivers predictable lean mass and strength improvements that hold up well post-cycle precisely because they are not dependent on water or estrogen-driven tissue changes.
References
| Source | Topic | Link |
|---|---|---|
| New England Journal of Medicine / PubMed | Bhasin S et al. 1996 — randomized controlled trial evaluating 600 mg/week testosterone enanthate in healthy men with and without resistance training; demonstrated significant increases in fat-free mass, muscle size, and strength, especially when supraphysiologic testosterone was combined with resistance training | Bhasin S, et al. (1996) ↗ |
| Sports Medicine / PubMed | Hartgens F & Kuipers H 2004 — review of androgenic-anabolic steroid effects in athletes; covers strength and bodyweight changes, body composition, erythropoiesis, lipid profiles, cardiovascular effects, endocrine suppression, hepatic effects, and psychological considerations across anabolic-androgenic steroid use in sport | Hartgens F & Kuipers H (2004) ↗ |
| NCBI Bookshelf / StatPearls | Anabolic steroids overview — clinical reference on anabolic-androgenic steroids including testosterone derivatives and injectable esterified AAS; covers androgen receptor mechanisms, HPG-axis suppression, adverse effects, misuse patterns, and monitoring considerations | StatPearls: Anabolic Steroids ↗ |
| NCBI Bookshelf / Endotext | Androgen physiology and pharmacology — comprehensive overview of testosterone biosynthesis, androgen receptor signaling, HPG-axis regulation, aromatization, synthetic androgen pharmacology, and endocrine suppression associated with exogenous androgen use | Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗ |
| Clinical Chemistry / PubMed | Franke WW & Berendonk B 1997 — detailed documentation of the East German state-sponsored doping program in which oral turinabol (4-chlorodehydromethyltestosterone) was widely administered to athletes; describes historical use patterns, administration practices, and the role of chlorodehydromethyltestosterone within systematic performance-enhancement programs | Franke WW & Berendonk B (1997) ↗ |
What is Turanabol Tablets?
Turanabol Tablets are an oral anabolic steroid (4-Chlorodehydromethyltestosterone) for lean muscle and strength; see What is Turanabol Tablets. It's effective—consult professionals for safe use.
What do Turanabol Tablets do?
They promote lean muscle, strength, and fat loss; see What Do Turanabol Tablets Do. They enhance definition—monitor with labs.
Are Turanabol Tablets safe?
They can be safe with responsible use, but risks include liver strain and testosterone suppression; see Are Turanabol Tablets Safe. Consult professionals for oversight.
How do I take Turanabol Tablets?
20-50 mg/day for men, 5-15 mg/day for women, split daily; see How to Take Turanabol Tablets. Start low—consult professionals for dosing.
How to cycle Turanabol Tablets?
6-8 weeks, 20-40 mg/day, PCT after 1-2 days; see How to Cycle Turanabol Tablets. Stack with testosterone—consult professionals.
What are the main benefits of Turanabol Tablets?
Commonly reported benefits include increased lean muscle mass, enhanced strength, improved recovery, support for body recomposition, and quality muscle gains with minimal water retention.
What are the possible side effects of Turanabol Tablets?
Potential side effects may include changes in cholesterol levels, liver stress, acne, elevated blood pressure, and suppression of natural testosterone production.
What makes Turanabol Tablets different from other oral anabolic steroids?
Turanabol Tablets are known for supporting lean, quality muscle development and strength gains while producing less water retention than many traditional mass-building oral anabolic compounds.
Related Products
- Promotes lean muscle growth and strength.
- Enhances muscle definition during cutting.
- Minimizes water retention and bloating.
- Supports recovery with mild anabolic effects.
- Promotes lean muscle growth and strength.
- Enhances fat loss for a defined physique.
- Improves muscle hardness and recovery.
- Delivers dry gains with minimal water retention.
